Cargando…

TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients

We investigated the hypothesis that the varying treatment efficacy of adjuvant 5-fluorouracil (5FU) in stage III colon cancer is linked to the TP53 mutational status. ABCSG-90 was a prospective randomized trial in which effect of adjuvant 5FU was studied in stage III colon cancer patients. Tumor mat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kandioler, Daniela, Mittlböck, Martina, Kappel, Sonja, Puhalla, Harald, Herbst, Friedrich, Langner, Cord, Wolf, Brigitte, Tschmelitsch, Jörg, Schippinger, Walter, Steger, Günther, Hofbauer, Friedrich, Samonigg, Hellmut, Gnant, Michael, Teleky, Bela, Kührer, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563117/ https://www.ncbi.nlm.nih.gov/pubmed/26425688 http://dx.doi.org/10.1016/j.ebiom.2015.06.003

Ejemplares similares

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
por: Schippinger, W, et al.
Publicado: (2007)

• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed—mutation rate of the marker higher than expected
por: Kappel-Latif, Sonja, et al.
Publicado: (2018)

A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer
por: Schippinger, W, et al.
Publicado: (2005)

Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation
por: Hofmann, Guenter, et al.
Publicado: (2006)

Standardized intraoperative application of an absorbable polysaccharide hemostatic powder to reduce the incidence of lymphocele after kidney transplantation – a prospective trial
por: Burghuber, Christopher K., et al.
Publicado: (2018)

A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options
por: Eisner, Florian, et al.
Publicado: (2015)

Desmoid Tumor Treated with Polychemotherapy Followed by Imatinib: A Case Report and Review of the Literature
por: Knechtel, Gudrun, et al.
Publicado: (2010)

LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study
por: Piringer, Gudrun, et al.
Publicado: (2023)

Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial
por: Pfeiler, G, et al.
Publicado: (2013)

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial
por: Gnant, M, et al.
Publicado: (2013)

Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients
por: Szkandera, Joanna, et al.
Publicado: (2014)

Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens
por: Tendl-Schulz, Kristina A., et al.
Publicado: (2020)

Effects of an enhanced iron dense foods offering in the daily meals served in geriatric institutions on measures of iron deficiency anemia
por: Sturtzel, Baerbel, et al.
Publicado: (2018)

Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy
por: Suppan, Christoph, et al.
Publicado: (2015)

A common hereditary single-nucleotide polymorphism in the gene of FAS and colorectal cancer survival
por: Hofmann, Guenter, et al.
Publicado: (2009)

Prognostic stratification of colorectal cancer patients: current perspectives
por: Schneider, Nora I, et al.
Publicado: (2014)

Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity.
por: KÃ¶hne, C. H., et al.
Publicado: (1998)

A Case of Therapy-related Acute Myeloid Leukemia Following Treatment with 5-Fluorouracil
por: Pinczés, László, et al.
Publicado: (2018)

Cisplatin and Short-Term 5-Fluorouracil Infusion for Paraneoplastic Microangiopathic Hemolytic Anemia in Gastric Cancer: A Case Report and Review of the Literature
por: Sanatani, M. S., et al.
Publicado: (2013)

Fluorouracil Catabolism in the Combination Treatment of Cyclophosphamide, Methotrexate and Fluorouracil
por: De Bruijn, Ernst A., et al.
Publicado: (1992)

LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy
por: Szkandera, J, et al.
Publicado: (2015)

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial
por: Fitzal, F, et al.
Publicado: (2015)

Combination of alitretinoin and topical 5-fluorouracil in Darier disease
por: Soenen, Anouk, et al.
Publicado: (2018)

Gastrointestinal effects of an attempt to avoid contracting COVID‐19 by ‘disinfection’
por: Binder, Lukas, et al.
Publicado: (2020)

MicroRNA-155-5p Contributes to 5-Fluorouracil Resistance Through Down-Regulating TP53INP1 in Oral Squamous Cell Carcinoma
por: Liu, Bowen, et al.
Publicado: (2022)

Assessment of Tp–e interval, Tp–e/QT, and Tp-e/QTc ratios in patients with acromegaly
por: ÇELİK, İbrahim Etem, et al.
Publicado: (2022)

TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model
por: Pabst, Gabriel, et al.
Publicado: (2020)

Let us integrate sexual health—do psychiatrists integrate sexual health in patient management?
por: Seitz, Tamara, et al.
Publicado: (2020)

Mixed lymphocytic and collagenous inflammation of the entire gastrointestinal tract under therapy with serotonin and norepinephrine reuptake inhibitors
por: Varelas, Ana I., et al.
Publicado: (2022)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Evaluation of Uric Acid as a Prognostic Blood-Based Marker in a Large Cohort of Pancreatic Cancer Patients
por: Stotz, Michael, et al.
Publicado: (2014)

Evaluation of Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio in patients with acute myocarditis
por: Ucar, Fatih Mehmet, et al.
Publicado: (2019)

Evaluation of Tp–e interval, Tp–e/QT ratio, and Tp–e/QTc ratio in patients with Behçet’s disease
por: Hidayet, Şıho, et al.
Publicado: (2019)

The „General Practice Class“ – an eligible compulsory course in undergraduate medical education: Didactical structure, teaching targets and implementation
por: Langosch, Claudia, et al.
Publicado: (2012)

Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potential
por: Mulvaney, Eamon P., et al.
Publicado: (2016)

Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
por: Fujii, Setsuro, et al.
Publicado: (1989)

Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival
por: Wimmer, K., et al.
Publicado: (2019)

Confocal Laser Endomicroscopy for Diagnosis of Barrett’s Esophagus
por: Neumann, Helmut, et al.
Publicado: (2012)

Secondary tumours of the ampulla of Vater: Case report and review of the literature
por: Sarocchi, Francesca, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0profgupoc3vr51pqjtqrln1nm